Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry.
Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry.
复制标题
使用液相色谱/串联质谱法测定人血浆中苔藓抑素 1 的方法的验证和实施。
DOI:
10.1016/j.ab.2004.10.030
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Baker,SharynD
中科院分区:
文献类型:
--
作者:
Zhao,Ming;Rudek,MichelleA;He,Ping;Smith,BDouglas;Baker,SharynD
A new sensitive and specific method using liquid chromatography/tandem mass spectrometry for determination of bryostatin 1 was developed and validated. Sample pretreatment involved a double liquid–liquid extraction step with a mixture of acetonitrile/n-butyl chloride (1/4, v/v). Separation of the compound of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra C18(50×2.1mm i.d., 3.5μm) analytical column with acetonitrile/water mobile phase (80:20, v/v) containing 0.1% formic acid using isocratic flow at 0.15mL/min for 13min. The analytes of interest were monitored by tandem mass spectrometry with electrospray positive ionization. The linear calibration curves were generated over the range of 50–2000pg/mL with values for the coefficient of determination of >0.99. The values for both within-day and between-day precision and accuracy were <15%. This method was used to characterize the plasma pharmacokinetics of bryostatin 1 at doses of 20μg/m2to optimize treatment with this agent.